LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
5.82
+0.31 (5.63%)
At close: Jun 26, 2026, 4:00 PM EDT
5.85
+0.03 (0.52%)
After-hours: Jun 26, 2026, 7:50 PM EDT
LENZ Therapeutics Stock Forecast
LENZ's stock price has decreased by -80.28% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for LENZ Therapeutics stock have an average target of 32.2, with a low estimate of 12 and a high estimate of 60. The average target predicts an increase of 453.26% from the current stock price of 5.82.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 13, 2026.
Analyst Ratings
The average analyst rating for LENZ Therapeutics stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 24, 2026 |
| Citi | Citi | Buy Reiterates $26 → $20 | Buy | Reiterates | $26 → $20 | +243.64% | May 13, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $29 → $31 | Buy | Maintains | $29 → $31 | +432.65% | May 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $48 → $38 | Buy | Reiterates | $48 → $38 | +552.92% | May 12, 2026 |
| Piper Sandler | Piper Sandler | Hold Downgrades $39 → $12 | Hold | Downgrades | $39 → $12 | +106.19% | May 12, 2026 |
Financial Forecast
Revenue This Year
19.03M
from 19.09M
Decreased by -0.29%
Revenue Next Year
64.52M
from 19.03M
Increased by 239.00%
EPS This Year
-4.56
from -2.85
EPS Next Year
-3.47
from -4.56
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 24.8M | 100.0M | |
| Avg | 19.0M | 64.5M | |
| Low | 12.8M | 23.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 30.2% | 425.4% | |
| Avg | -0.3% | 239.0% | |
| Low | -32.9% | 24.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -3.55 | -1.58 | |
| Avg | -4.56 | -3.47 | |
| Low | -5.56 | -5.09 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.